Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 109.74 -2.27 (-2.03%) Market Cap: 6.92 Bil Enterprise Value: 11.03 Bil PE Ratio: 22.63 PB Ratio: 1.87 GF Score: 78/100

Jazz Pharmaceuticals PLC at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 24, 2021 / 06:40PM GMT
Release Date Price: $173.5 (+10.18%)
Ami Fadia
SVB Leerink LLC, Research Division - MD of Biopharma & Generics and Senior Analyst

Good afternoon, everyone. Thank you for joining the next session with Jazz Pharmaceuticals. As a reminder, I'm Ami Fadia. I cover biopharma and generic here at SVB Leerink. And as we go through some of the Q&A, if you'd like me to ask any question on your behalf, feel free to send it over to me in the dashboard.

I have a pleasure of hosting Bruce Cozadd, who is the Chairman and CEO of Jazz. And along with him, Justin Gover, who's CEO of GW Pharma. Thank you both for joining us today. Also from Jazz's side, I've got Robert Iannone, who's the Head of Research and Development; as well as Kim Sablich, who's the Executive Vice President and General Manager of North America.

Questions & Answers

Ami Fadia
SVB Leerink LLC, Research Division - MD of Biopharma & Generics and Senior Analyst

With that, I'd like to thank everybody for joining.

And Bruce, if you could kick us off with some initial comments. You've had a few busy months

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot